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Abstract 44 
Scope: The aim of this study was to find out the relationship between the urine 45 
metabolomics fingerprints with the effects of cocoa and cocoa fiber on body weight 46 
and metabolism, microbiota composition and intestinal immunity.  47 
Methods and results: Wistar rats were fed, for two weeks, either a diet containing 48 
10% cocoa (C10, providing a final proportion of 0.4% polyphenols, 0.85% soluble 49 
fiber and 2.55% insoluble fiber), or two other diets with same proportion of soluble 50 
fiber: one based on cocoa fiber (CF, with a very low amount of polyphenols) and 51 
other containing inulin as a reference diet (REF). Twenty-four hours urine samples 52 
were collected after two weeks of diet and metabolomics analysis by 1H NMR 53 
spectroscopy was carried out. Concentration of fecal IgA and metabolic hormones in 54 
plasma were also quantified. Clear differences were observed between the urine from 55 
the C10 group and those from the CF group (Q2Y=0.89; p=0.001). The C10 diet 56 
decreased the fecal IgA, GLP-1 and glucagon concentrations. Urine metabolites 57 
mainly derived from cocoa catechin and methylxanthines were correlated with their 58 
effects on body weight, microbiota and immunity. 59 
Conclusions: These results allow us to establish a relationship between metabolomics 60 
of cocoa compounds and their effects. 61 
 62 
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1 Introduction 64 
Cocoa is considered a great source of bioactive compounds such as polyphenols and 65 
dietary fiber (DF) to whom consistent positive health effects have been attributed [1–66 
6]. Regarding its polyphenols, cocoa contains monomeric flavonoids such as the 67 
flavanols (+)-catechin and (–)-epicatechin, and mainly its oligomers and polymers 68 
known as procyanidins. These polymeric compounds are able to pass intact through 69 
the small intestine and to reach the colon [7], where they are metabolised by the 70 
intestinal microbiota. This conversion is crucial for their absorption and also for the 71 
generation of new compounds which are biologically more active than the original 72 
ones [7–11]. Thus, there is a growing body of evidence on the reciprocal relationship 73 
between bacteria and polyphenols that may help understand the documented benefits 74 
of polyphenols consumption: bacteria can be involved in the polyphenol metabolism 75 
and, at the same time flavonoids influence microbiota growth and composition [12]. 76 
In this sense, it has been extensively reported that both dietary polyphenols and the 77 
corresponding microbially-derived phenolic metabolites modulate the gut microbiota 78 
composition in in vitro, in vivo and clinical studies [10,13–15]. Cocoa flavonoids-79 
enriched diets have also shown microbiota modulatory effects [15,16]. 80 
Similar ability to modulate the microbiota composition has been attributed to the DF 81 
which has been described to indirectly lead to a different short chain fatty acids 82 
(SCFA) production [17–21]. This ability to modulate the microbiota composition as 83 
well as the SCFA production has also recently been associated to cocoa fiber-enriched 84 
intake in rats [20]. The DF fraction in cocoa is mainly rich in cellulose, followed by 85 
highly fermented pectic substances and hemicellulose, which is less fermentable than 86 
the former [22].  87 
After microbial transformation, the cocoa metabolites either from flavonoids or cocoa 88 
fiber (i.e. SCFA) are absorbed into the bloodstream, providing another source of 89 
potentially bioactive compounds [23,24]. To date, the microbial metabolites from 90 
flavanols, included in the term of food metabolome [25], are mainly metabolized by 91 
liver phase-II enzymes to hepatic conjugated derivatives that are subsequently 92 
eliminated in urine [11]. 93 
Previous preclinical studies carried out in our laboratory have evidenced that cocoa, 94 
cocoa flavanols and cocoa fiber modify some aspects of the intestinal and systemic 95 
immune response [3,16,20,26]. On the other hand, cocoa diet, but not its flavonoids or 96 
its fiber, is able to reduce the body weight gain [16,20,27]. Given that this effect on 97 
weight is not associated with a lower chow intake, it is necessary to deep into the 98 
mechanism involved in such effect. 99 
On the basis of this background, the aim of this study was to find out the relationship 100 
between the urine metabolomics fingerprints by 1H NMR spectroscopy with the 101 
effects of cocoa on body weight and metabolism, microbiota composition and 102 
intestinal immunity. The particular involvement of cocoa fiber in such effects has also 103 
been studied.  104 
2  Materials and methods 105 
2.1 Animals and diets 106 
Female Wistar rats (3-week-old) were obtained from Janvier (Saint-Berthevin, 107 
France) and housed in cages under conditions of controlled temperature and humidity 108 
in a 12:12 light-dark cycle. The rats were randomly distributed into three dietary 109 
groups: cocoa (C10), cocoa fiber (CF) and reference (REF) groups (n=10/each). The 110 
C10 group received chow containing 10% cocoa that finally provided a 0.4% of 111 
polyphenols, 0.85% soluble fiber and 2.55% of insoluble fiber; the CF group received 112 
a diet with the same cocoa soluble and insoluble fiber proportions as the C10 group 113 
but with a very low amount of polyphenols (<0.02%); and the REF group received the 114 
same amount of soluble fiber as the C10 group (0.85%) but as inulin in order to 115 
distinguish the particular effect of cocoa fiber. Natural Forastero cocoa and cocoa 116 
fiber powders (provided by Idilia Foods S.L., formerly Nutrexpa S.L.), Barcelona, 117 
Spain) with 4.02% and 0.35% of polyphenols, respectively, were used to elaborate the 118 
C10 and CF diets. Inulin from chicory roots (Fibruline® Instant; InnovaFood 2005, 119 
S.L., Barcelona, Spain) was used as a reference soluble fiber. The three experimental 120 
diets were elaborated on basis of the AIN-93M formula by subtracting the amount of 121 
carbohydrates, proteins, lipids and insoluble fiber provided by the corresponding 122 
supplement. The resulting chows were isoenergetic and had the same proportion of 123 
macronutrients (carbohydrates, proteins and lipids) and insoluble fiber as the REF diet 124 
as has been previously reported [20]. Animals were given free access to water and 125 
chow. The diets lasted for three weeks.  126 
Body weight and food intake were monitored throughout the study. Experiments were 127 
performed according to the Guide for the Care and Use of Laboratory Animals, and 128 
experimental procedures were approved by the Ethical Committee for Animal 129 
Experimentation of the University of Barcelona (ref. 358/12). 130 
2.2 Sample collection and processing 131 
The 24 h urine samples were collected at 15 days after beginning with the nutritional 132 
intervention by means of metabolic cages. Urines were then centrifuged and were 133 
kept at – 80 ºC until rat urine metabolic fingerprint profile analysis using 1H NMR 134 
spectroscopy. Moreover, blood samples were collected after three weeks of diet using 135 
EDTA-treated tubes (Sardstedt AG & Co, Nümbrecht, Germany) and plasma was 136 
kept at - 20 ºC prior to metabolic hormones determination. Fecal samples were also 137 
collected at the third week of diet and the homogenates were obtained as previously 138 
described [20] and frozen at - 20 ºC until analysis. 139 
2.3 Sample preparation for 1H NMR analysis 140 
Urine samples were defrosted and prepared for 1H NMR spectroscopy by combining 141 
400 µL of sample with 200 µL of phosphate buffer (pH 7.4; 100% D2O) containing 142 
1 mM of 3-trimethylsilyl-1-[2,2,3,3-2H4] propionate (TSP) as an external standard and 143 
2 mM sodium azide as a bacteriocide. Samples were vortexed to mix and particules 144 
were removed by centrifugation (13000 g for 10 min) prior to transferring 550 µL to a 145 
5 mm NMR tube. Standard one-dimensional 1H NMR spectra of the urine samples 146 
were acquired on a 500 MHz Bruker NMR spectrometer using a standard noisy 147 
experiment incorporating a pre-saturation pulse to attenuate the water signal. This 148 
experiment consisted of [recycle delay (RD)-90○-t1-90○-tm-90○-acquire free induction 149 
decay]. The water signal was suppressed by irradiation during the RD of 2 s, with a 150 
mixing time (tm) of 10 µs. The acquisition time was set to 2.91 s and the 90○ pulse 151 
length was 15.87 µs. For each sample, 8 dummy scans were followed by 128 scans 152 
and collected in 64K data points using a spectral width of 16 ppm. Prior to data 153 
analysis, NMR spectra were phased, corrected for baseline distortions and calibrated 154 
using the reference standard TSP. 1H NMR spectra (δ 0.2-10.0) were digitized into 155 
consecutive integrated spectral regions (~20,000) of equal width (0.00055 ppm) using 156 
Matlab (Mathworks). The regions containing signals from urea (δ 5.5 – 6.0) and the 157 
residual water (δ  4-7 – 5.2) were removed to minimize baseline effects arising from 158 
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imperfect water suppression. Chemical shift variation was minimized across the 159 
dataset by applying a recursive segment-wise peak alignment (RSPA) algorithm to 160 
each spectrum. Each spectrum was normalized to unit area to account for variation in 161 
sample concentration. 162 
2.4 Quantification of metabolic hormones in plasma 163 
Plasma concentrations of ghrelin, glucagon, glucagon-like peptide (GLP)-1 and leptin 164 
were determined in plasma using the Bio-Plex Pro™ Diabetes Assay (Bio-Rad, 165 
Madrid, Spain) according to the manufacturer’s instructions. Analysis was carried out 166 
with the Bio-Plex® MAGPIX™ Multiplex Reader and the Bio-Plex Data Pro™ 167 
software (BioRad) as in previous studies [28]. The limits of quantification can be 168 
found as Supporting information. 169 
2.5 Fecal IgA quantification  170 
The concentration of IgA in feces was quantified by ELISA following the 171 
manufacturer’s instructions (Bethyl Laboratories, Inc., Montgomery, TX, USA). 172 
Absorbance was measured in a microplate photometer (LabSystems Multiskan) and 173 
data were interpolated using ASCENT version 2.6 software (Thermo Fisher 174 
Scientific, Barcelona, Spain) into the standard curves, and expressed as ng/mg of 175 
feces. 176 
2.6 Statistical analysis 177 
Statistical analysis for body weight, chow intake, fecal IgA and metabolic hormones 178 
was performed using the software package IBM SPSS Statistics 22.0 (SPSS, Inc. 179 
USA). Levene’s and Kolmogorov–Smirnov tests were applied to assess variance 180 
equality and normal distribution, respectively. Conventional one-way ANOVA was 181 
performed when normal distribution and equality of variance existed. The Bonferroni 182 
test was applied when specific cocoa intake had a significant effect on the dependent 183 
variable. Non-parametric Mann–Whitney U and Wilcoxon tests were used in order to 184 
assess significance for independent and related samples, respectively.  185 
Multivariate modeling was performed in Matlab using in-house scripts. This included 186 
principal components analysis using pareto scaled data and orthogonal projection to 187 
latent structures-discriminant analysis (OPLS-DA) using a unit variance scaling 188 
approach. Pairwise OPLS-DA models were constructed to aid model interpretation 189 
and identify discriminatory metabolites between the study groups. Here, 1H NMR 190 
spectroscopic profiles served as the descriptor matrix (X) and the experimental groups 191 
(REF, C10, CF) were used pairwise as the response variable (Y). Orthogonal signal 192 
correction filters were used to remove variation in the descriptor matrix unrelated to 193 
the response variable to assist model interpretation. Loading coefficient plots were 194 
generated by back-scaling transformation where covariance is plotted between the Y-195 
response matrix and the signal intensity of the metabolites in the NMR data (X). 196 
These plots are colored based on the correlation coefficient (r2) between each 197 
metabolite and the Y-response variable, with red indicating strong significance and 198 
blue indicating weak significance. The predictive performance (Q2Y) of the model 199 
was calculated using a seven-fold cross validation approach and model validity was 200 
established by permutation testing (1.000 permutations).  201 
Clustering analysis. Unsupervised hierarchical clustering analysis (HCA) was 202 
performed to identify general patterns of metabonomic variation between samples. To 203 
do so, we used the normalized levels of metabolites identified to contribute to class 204 
separation through the OPLS-DA models. For comparative analysis across different 205 
metabolites, data were standardized as z-scores across samples for each metabolite 206 
before clustering, so that the mean is 0 and the standard deviation is 1. This 207 
standardized matrix was subsequently used in unsupervised HCA for samples and 208 
metabolites using Euclidean distance and average linkage, by means of the pdist and 209 
linkage functions in the MATLAB bioinformatics toolbox. Heatmaps and 210 
dendrograms following HCA were generated with MATLAB imagesc and 211 
dendrogram functions, respectively. In the heatmaps, a red-blue color scale is used so 212 
that shades of red and blue represent higher and lower values, respectively, compared 213 
with the mean. Different diet groups are color-coded and shown under the 214 
dendrogram for each sample.  215 
Correlation analysis. To explore the functional correlation between the changes on 216 
gut microbiome, body weight, metabolism and intestinal immunity and metabonome 217 
perturbations, Spearman´s correlation analyses were performed. The Benjamini-218 
Hochberg method was used to adjust p-values for multiple testing considering a 5% 219 
false discovery rate (FDR). 220 
 221 
3  Results 222 
3.1  Body weight and chow intake 223 
Body weight and chow intake were monitored weekly throughout the study (Fig. 1). 224 
Although the initial body weight was similar among the groups (44.4 ± 0.7 g), a 225 
statistically slower body weight gain was observed already at day 7 in cocoa-fed 226 
animals in comparison to the REF group (p < 0.05) and lasted until the end of the 227 
study (Fig. 1A). This effect was not related to lower chow intake, which was similar 228 
throughout the study among all experimental groups (Fig. 1B). No changes in body 229 
weight gain were found as a result of CF diet intake. 230 
3.2  Metabolic hormones  231 
The metabolic hormones quantified in plasma after three-week dietary intervention 232 
for all groups are summarized in Table 1. Both the C10 and the CF diets increased the 233 
concentration of ghrelin compared to that of the REF animals (p < 0.05). This 234 
increase was higher in the C10 group compared to the CF group (p < 0.05).  Both 235 
diets also resulted in a lower plasma GLP-1 concentration in comparison with the 236 
REF group (p < 0.05). Moreover, the C10 diet reduced the glucagon concentration in 237 
plasma compared to the REF and CF diets (p < 0.05). The leptin concentration was 238 
not significantly affected after the C10 diet but it was up-regulated as a result of the 239 
CF diet intake compared to the rest of the groups (p < 0.05) (Table 1). 240 
3.3  Fecal IgA 241 
The C10 diet intake resulted in a significantly attenuation of the IgA concentration 242 
compared to the rest of the groups (p < 0.05) (Fig. 2). The CF diet did not produce 243 
any change in the IgA concentration, which was similar to that quantified in the REF 244 
group.  245 
3.4  Urinary metabolic profile 246 
An OPLS-DA model with strong predictive ability (Q2Y = 0.93; p = 0.001) was 247 
returned comparing the metabolic profiles from rats receiving the C10 diet and the 248 
REF diet (Fig. 3A and 4). Rats fed the C10 diet excreted higher amounts of cocoa-249 
derived metabolites. These include N-methylnicotinic acid (NMNA; trigonelline), 250 
nicotine mononucleotide (NMN), theobromine, xanthine, 1-methylxantine (1-MX), 3-251 
methylxantine (3-MX), 7-methylxanthine (7-MX), imidazole, dimethyluric acid 252 
(DMU), and catechin derivatives. The excretion of cocoa polyphenol microbial-253 
derived metabolites such as 4-hydroxypropionic acid (4-HPA), hippurate, and 254 
phenylacetylglutamine (PAG) was also increased in the urine of C10 animals. 255 
Alternatively, the higher excretions of 4-HPA, PAG and indole-3-acetate could be 256 
derived from tyramine, 2-phenylethylamine, and tryptamine, respectively, which are 257 
the main moamines contained in cocoa. Moreover, the urine from these rats had 258 
higher amounts of 2-hydroxyisobutyrate (2-HIB), another microbial-derived 259 
metabolite, as well as taurine On the other hand, those animals receiving the C10 diet 260 
excreted lower amount of energy metabolism-related metabolites (acetone, citrate, 261 
2-oxoglutarate (2-OG) and N-methylnicotinamide (NMND) compared to the REF 262 
group. Other metabolites excreted in lower amounts include metabolites related to 263 
endogenous (α-keto-isocaproate (αKIC), α-keto-methylvalerate (αKMV), 264 
hydroxymethylbutyrate (HMB), 3-hydroxyisobutyrate (3-HIB) and glycine) and 265 
microbial-derived (3-indoxyl-sulfate (3-IS), 4-cresol sulfate (4-CS) and 4-cresol 266 
glucuronide (4-CG)) aminoacid metabolism; metabolites related to choline 267 
metabolism (dimethylamine (DMA), dimethylglycine (DMG) and choline), and 268 
metabolites related to dietary metabolism (sucrose, glucose, tartrate). The C10 diet 269 
also resulted in a lower excretion of others metabolites such as sebacate, 4-270 
guanidinobutanoate, creatinine, allantoin, and pseudouridine compared to the REF 271 
diet. 272 
Regarding CF diet, a clear metabolic variation was observed in the urine from rats fed 273 
the CF diet compared to those fed the REF diet (Fig. 3B and 4; OPLS-DA model 274 
Q2Y = 0.65; p = 0.001). Cocoaderived metabolite NMNA and caffeine-related 275 
metabolites such as theobromine, xanthine, 1-MX, 3-MX, 7-MX, and DMU were 276 
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found in the urine of rats receiving the CF diet but not those receiving the REF diet. 277 
Moreover, rats following a CF diet excreted greater amounts of 2-HIB (microbial 278 
metabolism-derived metabolite), IAA (metabolite derived from the amino acid 279 
metabolism), NMN (cocoa derived metabolite) and citrate, acetone and NMND all of 280 
them derived from the energy metabolism as well as sugars (sucrose and glucose), 281 
acetate and tartrate, derived from the dietary metabolism compared to those fed the 282 
REF diet. Lower amounts of microbial metabolism- (4-HPA, hippurate, 3-IS and 283 
PAG), amino acid- (αKI), choline- (DMG) and others- (sebacate, 4-284 
guanidinobutanoate, ethanol, creatinine, allantoin and pseudouridine) related 285 
compounds were found in the CF group when compared to REF group.    286 
Finally, the OPLS-DA model contrasting the urinary metabolic phenotypes from rats 287 
receiving the C10 diet and those fed the CF diet (Q2Y = 0.89; p = 0.001) also showed 288 
some clear differences. As expected, rats consuming the C10 diet excreted higher 289 
levels of methylxanthines and its metabolites theobromine, xanthine, 1- and 3-290 
methylxanthine, imidazole, DMU as well as the cocoa (NMNA, NMN) and catechin 291 
derivatives compared to those fed the CF diet. The C10 diet fed animals also excreted 292 
higher amount of metabolites derived from the microbial metabolism (4-HPA, 293 
hippurate and PAG) and from the amino acid metabolism (IAA and taurine). 294 
However,  the C10 diet fed animals eliminated lower amounts of amino acid 295 
metabolism- (αKMV, HMB), energy metabolism- (acetone, 2-OG, NMND and 296 
citrate); choline (DMA and choline); microbial metabolism derivate (3-IS); dietary 297 
metabolism-related metabolites (sucrose and glucose) among others (sebacate, 4-298 
guanidinobutanoate, fumarate, allantoin and pseudouridine) compared to those fed the 299 
CF diet.  300 
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3.5  Correlations between urine metabolites and studied variables  301 
The correlation analysis between the urine metabolic fingerprints with the effects of 302 
cocoa on body weight, microbiota composition (reported previously [20,29]) and 303 
intestinal immunity was also studied (Fig. 5). Regarding body weight and metabolic 304 
hormones, when samples from all the groups were considered together, the body 305 
weight showed a significant inverse correlation with the detected amounts of the 306 
cocoa metabolism- and amino acid metabolism-related metabolites in urine. 307 
Moreover, a significant positive correlation was found between ghrelin concentration 308 
and the amount of cocoa derivate metabolites as well as between the concentration of 309 
plasma glucagon and the amount of choline. 310 
In a previous study we characterized the microbiota composition after both the C10 311 
and the CF diets intake [20]. Using these results we found that, the proportion of 312 
Streptococcus genus presented a significant inverse correlation with the amount of 313 
epicatechin (derived from the cocoa metabolism) and 4-HPA (from the amino acid 314 
metabolism) determined in urine. In addition, a positive correlation was found 315 
between Bifidobacterium counts and the amount of amino acid metabolism-related 3-316 
IS. When the Firmicutes/Bacteroidetes ratio was considered, a strong positive 317 
correlation was observed between its values and those from the choline-related 318 
metabolites. 319 
Concerning the immunological parameters, the fecal IgA concentration had a 320 
significant positive correlation with the amount of DMA and DMG (from choline 321 
metabolism) and allantoin at the same time that had an inverse correlation with the 322 
amount of cocoa derivate metabolites (theobromine, xanthines and DMU).  323 
3.6  Correlations between metabolic hormones and studied variables  324 
The correlation analysis between the effects of cocoa on the metabolic hormones, 325 
body weight, microbiota composition [20] and intestinal immunity was also studied 326 
(Fig. 6). When samples from all the groups were considered together, the body weight 327 
showed a significant positive correlation with the proportion of Bifidobacterium, 328 
Clostridium histolyticum/C. perfringens, Streptococcus genus, the 329 
Firmicutes/Bacteroidetes ratio as well as with the concentration of butyric acid in 330 
cecum content. There was also a positive correlation between the body weight and 331 
both the glucagon and leptin plasma concentrations whereas it was negatively 332 
correlated with the plasma ghrelin concentration.  333 
The metabolic hormones also showed association with the microbiota composition 334 
and functionality. Particularly, the ghrelin concentration was negatively correlated 335 
with the Bifidobacterium spp., Lactobacillus spp., Clostridium histolyticum/C. 336 
perfringens, Streptococcus spp. proportion as well as with the 337 
Firmicutes/Bacteroidetes ratio, and the cecal butyric and the fecal IgA concentrations.  338 
Moreover, the leptin concentration in plasma was positively correlated with the fecal 339 
counts of Bifidobacterium spp. and Streptococcus spp., which, together with the 340 
Firmicutes/Bacteroidetes ratio and the cecal butyric concentration, were also 341 
positively correlated with the glucagon concentration.  342 
Regarding the fecal IgA, its concentration was positively associated with the fecal 343 
Streptococcus spp. counts and the rat’s body weight. 344 
4  Discussion 345 
After ingestion of cocoa, both its polymeric flavanols and fiber reach the colon intact, 346 
where commensal bacteria have an opportunity to metabolize them [7,10] resulting in 347 
more active metabolites which can influence the intestinal immune system and lipid 348 
metabolism. Previous studies showed that diets containing either 10% cocoa, cocoa 349 
polyphenols or cocoa fiber modulate the microbiota composition and the intestinal 350 
immune system in rats [16,20,29]. Here we demonstrate that both the whole cocoa 351 
and the fiber from cocoa resulted in distinct urinary metabolome patterns which are 352 
differentially correlated with the effects of cocoa on body weight, metabolic 353 
hormones and the immunological status determined here and also with the microbiota 354 
composition reported previously [20]. There are also significant correlations between 355 
body weight, metabolic hormones profile and IgA concentration with the microbiota 356 
composition and functionality. 357 
The main differences observed in the urine metabolomic fingerprints from all the 358 
experimental diets, and in line with previous controlled cocoa dietary intervention 359 
studies [30,31], was the expected greater amounts of cocoa-derived metabolites. 360 
These include the caffeine metabolites and the catechin derivatives, produced by the 361 
gut microbiota, that have been identified in the urine from the animals fed the10% 362 
cocoa diet but not in those fed the cocoa fiber diet. These results confirm the lower 363 
concentrations of polyphenols and methylxantines in the cocoa fiber powder used in 364 
the present study to elaborate the CF diet.  365 
Agreeing with previous studies [20,29,32–34], a significant lower body weight gain 366 
has been observed in the animals fed the 10% cocoa diet. Although different feasible 367 
mechanisms involved in cocoa effect on body weight and lipid metabolism have been 368 
already proposed [20,35], we aimed to evaluate whether the cocoa intake affects the 369 
metabolic hormones. In this sense, we have observed that the effect of cocoa on body 370 
weight was accompanied by a tendency to reduce the leptin concentration in plasma. 371 
Leptin is secreted by adipocytes and it provides the central nervous system with a 372 
signal of the state of the body energy balance, which helps to control the appetite and 373 
food intake, and to maintain a stable body weight [36]. However, given that there was 374 
no difference in food intake between dietary groups along the study, the leptin 375 
pathway can be discarded as the main mechanism by which cocoa influences the body 376 
weight. Likewise, although the cocoa fiber intake increased the concentration of leptin 377 
in plasma at the end of the study, it did modify neither the chow intake nor the body 378 
weight gain in those animals. On the contrary we expected the C10-fed animals had 379 
the highest ghrelin concentration compared to the rest of the groups. Although it is 380 
known that ghrelin stimulates the appetite and food intake, increases fat mass 381 
deposition and weight gain and influences glucose and lipid metabolism [37], in the 382 
present study it did not provoked changes in chow intake. In fact, the ghrelin 383 
concentration was negatively correlated with the body weight when all samples were 384 
considered together. 385 
We have also evaluated the impact on glucagon, a peptide hormone involved in the 386 
glucose metabolism. In this report it can be observed that the diet containing the 387 
whole cocoa, but not the one containing only cocoa fiber, significantly reduced the 388 
glucagon level. These results, which are in line with previous studies [28], brings to 389 
light the lack of contribution of cocoa fiber to these effects.  390 
Furthermore, it have been reported that the effects of body weight on the gut 391 
microbiota may be mediated, in part, by changes in circulating leptin concentration 392 
[38] since this hormone stimulates the mucin production in the intestine which could 393 
affect the composition of the microbiota [39]. Concurrently, the microbiota is able to 394 
partially mediate the appetite control by regulating the level and type of 395 
autoantibodies targeting the appetite-regulating hormones [40,41]. In the present 396 
study we also evaluated the association between the metabolic hormones and the 397 
microbiota composition characterized after both the C10 and the CF diets intake. In 398 
this sense, a negative correlation was observed when all samples were considered 399 
together between the ghrelin concentration and the proportion of Lactobacillus, which 400 
agrees with other authors [36], as well as Clostridium histolyticum/C. perfringens 401 
genera.  Besides showing a negative correlation with the ghrelin plasma 402 
concentration, the proportions of Bifidobacterium and Streptococcus genera as well as 403 
the Firmicutes/Bacteroidetes ratio showed a positive correlation with the leptin 404 
concentration, results which are partially in line with previous studies [36]. 405 
Associated to the microbiota composition, microbiota functionality can better explain 406 
its pivotal role in host metabolism. In this regard, and in disagreement with our 407 
results, it has been reported a food intake inhibition caused by two of the main SCFA 408 
(butyrate and propionate) through stimulating gut hormones [42]. In our study, the 409 
ghrelin concentration has been positively correlated with the butyric concentration in 410 
cecum content. Moreover, a positive correlation has been observed between ghrelin 411 
concentration and the amounts of theobromine, a methylxanthine present in cocoa in a 412 
high concentration. Nonetheless, these theobromine metabolites were also negatively 413 
associated with body weight, so oppositely to what it was observed, it would be 414 
expected higher chow intake together with a lower body weight gain in the 10% 415 
cocoa-fed animals. Thus these results evidence the strong contribution of theobromine 416 
and its metabolites to the effect of cocoa on body weight. Additionally, an inverse 417 
association was found between the body weight and the presence of metabolites 418 
derived from the microbial metabolism, especially with PAG and 4-HPA. Thus, it 419 
might be proposed that the direct modulatory effects of cocoa on microbiota 420 
composition [29] are, among others, a key factor of this lower body weight gain. In 421 
fact, studies carried out in our laboratory showed that the C10 diet intake decreased 422 
the counts of Staphylococcus and Streptococcus (belonging to the Firmicutes phylum) 423 
and increased those of Bacteroides (included in Bacteroidetes phylum) leading to a 424 
lesser ratio of Firmicutes to Bacteroidetes [20,29], which has been extensively 425 
associated with obesity or weight loss [35].  In line with these results, here an inverse 426 
correlation has also been found between the counts of Streptococcus and the excreted 427 
amounts of 4-HPA and epicatechin in urine.   428 
Although the attenuating effect of the whole cocoa diet and the cocoa polyphenols-429 
enriched diet on the Ig synthesis has already been reported [3,16,32], less is known 430 
about the impact of a cocoa fiber diet on the IgA synthesis. Here, the C10 diet resulted 431 
in a significantly lower fecal IgA concentration at the end of the study, which 432 
reinforces this cocoa effect while the cocoa fiber intake did not produce changes on 433 
IgA concentration. In fact, it has been already reported the cocoa interaction with the 434 
mechanisms involved in the IgA synthesis in the small intestine [26]. Moreover, a 435 
significant inverse correlation was found between the fecal IgA concentration and the 436 
amounts of cocoa-derived metabolites, including the caffeine metabolites and the 437 
catechin derivatives, resulting from the gut microbiota metabolism. Overall it suggests 438 
the role of both cocoa polyphenols and methylxanthines which after microbiota 439 
metabolism may lead to the formation of compounds that interact with the 440 
mechanisms involved in the IgA secretion and/or synthesis. Indeed, not only the 441 
microbiota-generated metabolites are important, but also the microbiota composition. 442 
In this sense, the lower counts of Streptococcus genus are positively well correlated 443 
with the lessening of the fecal IgA concentration.  444 
In summary, we have demonstrated that a cocoa diet led to a higher excretion of 445 
metabolites related to its main bioactive components in young Wistar rats. Moreover, 446 
cocoa diet intake resulted in a lower fecal IgA secretion as well as differential 447 
metabolic hormones profile. In addition, most of the effects caused by the cocoa 448 
intake are well correlated among them as well as with the amount of excreted 449 
metabolites in urine derived from the cocoa metabolism. Therefore it suggests the 450 
contribution of others cocoa compounds, but not the cocoa fiber, on such effects.  451 
Further studies should be carried out in order to evaluate the precise contribution of 452 
methylxanthines present in cocoa to such effects.  453 
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Figure legends  610 
Figure 1. Body weight increase (%) compared to the baseline (A) and chow intake 611 
(%) compared to the REF diet which represents 100% (B) monitored throughout the 612 
nutritional intervention. Values are expressed as mean ± SEM (n=10). * p < 0.05 vs 613 
REF diet; and ‡ p < 0.05 vs CF diet. 614 
Figure 2. Fecal IgA concentration determined after three weeks of nutritional 615 
intervention. Results are expressed as mean ± SEM (n = 9 -10). *p < 0.05 vs REF diet; 616 
‡ p < 0.05 vs CF diet. 617 
Figure 3. Orthogonal projection to latent structures-discriminant analysis (OPLS-DA) 618 
comparing the urinary metabolic profiles of rats receiving different dietary regimens. 619 
Coefficient plots extracted from the OPLS-DA models comparing rats receiving REF 620 
diet with C10 diet (A); REF diet with CF diet (B); and C10 diet with CF diet (C). 621 
αKMV, α-keto-β-methyl-n-valerate; αKIC, α-ketoisocaproate; 1-MX, 1-622 
methylxanthine;2-HIB, 2-hydroxyisobutyrate; 2-OG, 2-oxoglutarate; 3-HIB, 3-623 
hydroxyisobutyrate; 3-IS, 3-indoxyl-sulfate;3-MX, 3-methylxanthine; 4-GB, 4-624 
guanidinobutanoic acid; -CS, 4-cresol sulfate; 4-CG, 4-cresol glucuronide; HMB, β-625 
hydroxy-β-methylbutyrate; 4-HPA, 4-hydroxypropionic acid;7-MX, 7-626 
methylxanthine; C10, 10% cocoa diet; CF, cocoa fiber diet;DMA, dimethylamine; 627 
DMG, dimethylglycine; DMU, dimethyluric acid; IAA, indoleacetic acid; NAG, N-628 
acetylglycoprotein; NMN, nicotine mononucleotide; NMNA, N-methyl-nicotinic 629 
acid; NMND, N-methyl-nicotinamide; PAG, phenylacetylglycine; REF, Reference 630 
diet; TMAO, trimethylamine N-oxide. 631 
Figure 4. Dendrogram and heatmap representation of unsupervised hierarchical 632 
clustering (HCA) of the metabonome for all rats. Each column corresponds to a single 633 
rat and each row corresponds to a specific metabolite. Metabolites identified to 634 
contribute to the separation between diets through OPLS-DA models were used for 635 
sample clustering. Metabolite z-score transformation was performed on the levels of 636 
each metabolite across samples, with blue denotating a lower and red a higher level 637 
compared to the mean. Metabolites and samples are clustered using correlation 638 
distance and average linkage and color coded by diet (Brown, cocoa diet; Orange, 639 
cocoa fiber; Blue, REF) or pathway (Red: aminoacid metabolism; Purple: microbial 640 
metabolism; Orange: dietary; Green: energy metabolism; Yellow: choline 641 
metabolism; Blue: miscellaneous; Pink: cocoa metabolites), respectively. HCA 642 
grouped the urinary metabolic profiles from the C10-fed animals together and distinct 643 
from the other studied animals. Profiles from animals receiving the CF diet clustered 644 
together and were separate from the REF diet. 645 
Figure 5. Correlations between metabolites and responses. The intensity of the colors 646 
represents the degree of correlation, with red and blue indicating positive and negative 647 
correlations, respectively. Metabolites identified to contribute to the separation 648 
between diets through OPLS-DA models were to obtain the correlations. The order of 649 
metabolites is the same obtained from the unsupervised hierarchical clustering in 650 
Figure 4. Only significant correlations after applying a Benjamini and Hochberg 651 
procedure for controlling for a false discovery rate of 5% are shown. Correlation 652 
coefficients were based on Spearman’s correlation. 653 
654 
Tables 655 
Table 1. Metabolic hormones in plasma after three weeks of nutritional intervention. 656 
Results are expressed as mean ± SEM (n = 7). * p < 0.05 vs REF diet; † p < 0.05 vs 657 
C10 diet and ‡ p < 0.05 vs CF diet. 658 
 659 
 REF C10 CF 
Ghrelin (ng/mL) 30.57 ± 3.86 98.63 ± 18.73*‡ 43.59 ± 4.27* 
GLP-1 (pg/mL) 29.4 ± 16.4 7.4 ± 3.1* 4.2 ± 0.2* 
Glucagon (pg/mL) 180.1 ± 25.3 100.4 ± 3.1*‡ 166.2 ± 26.9 
Leptin (pg/mL) 647.7 ± 135.5 335.4 ± 127.5 968.7 ± 177.6*† 
